Penn Medicine Lancaster General Health — Lancaster, Pennsylvania

Penn Medicine Lancaster General Health is a clinical research site located in Lancaster, Pennsylvania, United States 17601.

Crixeo Health Trust Score: 73/100 (FAIR). This profile has not yet been claimed by the site owner.

Penn Medicine Lancaster General Health has participated in 7 clinical trials with 6 currently active.

Therapeutic areas: Relapsed or Refractory Multiple Myeloma, Non Small Cell Lung Cancer Metastatic, Newly Diagnosed NSCLC.

Sponsors: Janssen Research & Development, LLC, Charu Aggarwal, Lancaster General Hospital.

Sponsor Feasibility Report

Trust Score: 73/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Penn Medicine Lancaster General Health?

Penn Medicine Lancaster General Health has a Crixeo Trust Score of 73/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Penn Medicine Lancaster General Health conducted?

Penn Medicine Lancaster General Health has 7 clinical trials on record, with 6 currently active. Their work covers Relapsed or Refractory Multiple Myeloma, Non Small Cell Lung Cancer Metastatic, Newly Diagnosed NSCLC.

Is Penn Medicine Lancaster General Health accredited by Crixeo Health?

Yes — Penn Medicine Lancaster General Health holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Penn Medicine Lancaster General Health?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.